Methods

74
Neonates receiving vancomycin as a continuous infusion in one of three NICUs The loading dose is infused over 60 minutes and followed by the maintenance dose 
114
The safety evaluation was focused on nephrotoxicity, which was evaluated based on Figure 1 .
156
The relative error between observed and target TDM concentrations was not dose regimen was established and tested prospectively using the identified covariates.
219
In the present study, we have shown a great improvement in the target attainment rate Obviously, the reduced blood loss in newborns has a considerable clinical benefit. Of of vancomycin administrated as a continuous infusion.
237
A limitation of our study is that all the patients were followed until the end of 238 hospitalization and the long-term follow-up data was not available. Obviously, the 239 developmental toxicity, e.g. ototoxicity, cannot be evaluated in our study and a long-
240
term safety study of vancomycin is required in neonates (16 
